Teva to pay $225M to settle cholesterol drug price-fixing charges
The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to...
The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to...
In a major study, a new kind of cholesterol-lowering drug helped people who can’t take the first choice, pills called st...
U.S. regulators have approved a new type of cholesterol-lowering drug aimed at millions of people who don't get eno...